Could simpler tests improve GI care?
The @myueg.bsky.social Week 2026 congress explored blood biomarkers for colorectal cancer, microbiome profiling for ulcerative colitis, and gut transit testing.
Join EMJ for free for more gastroenterology insights: www.emjreviews.com/mailing-list/
#UEGWeek2026
The @myueg.bsky.social Week 2026 congress explored blood biomarkers for colorectal cancer, microbiome profiling for ulcerative colitis, and gut transit testing.
Join EMJ for free for more gastroenterology insights: www.emjreviews.com/mailing-list/
#UEGWeek2026
October 29, 2026 at 11:09 AM
Could simpler tests improve GI care?
The @myueg.bsky.social Week 2026 congress explored blood biomarkers for colorectal cancer, microbiome profiling for ulcerative colitis, and gut transit testing.
Join EMJ for free for more gastroenterology insights: www.emjreviews.com/mailing-list/
#UEGWeek2026
The @myueg.bsky.social Week 2026 congress explored blood biomarkers for colorectal cancer, microbiome profiling for ulcerative colitis, and gut transit testing.
Join EMJ for free for more gastroenterology insights: www.emjreviews.com/mailing-list/
#UEGWeek2026
What’s emerging in IBD research from UEG Week 2026?
We've compiled selected clinical insights from Barcelona, covering emerging therapies, key research findings, and their implications for IBD care.
gastroagi.com/clinical-con...
#MedSky #UEGWeek2026 #IBD #Gastroenterology #CrohnsDisease
We've compiled selected clinical insights from Barcelona, covering emerging therapies, key research findings, and their implications for IBD care.
gastroagi.com/clinical-con...
#MedSky #UEGWeek2026 #IBD #Gastroenterology #CrohnsDisease
October 29, 2026 at 5:30 AM
What’s emerging in IBD research from UEG Week 2026?
We've compiled selected clinical insights from Barcelona, covering emerging therapies, key research findings, and their implications for IBD care.
gastroagi.com/clinical-con...
#MedSky #UEGWeek2026 #IBD #Gastroenterology #CrohnsDisease
We've compiled selected clinical insights from Barcelona, covering emerging therapies, key research findings, and their implications for IBD care.
gastroagi.com/clinical-con...
#MedSky #UEGWeek2026 #IBD #Gastroenterology #CrohnsDisease
From #UEGWeek2026 - The synthetic corticosteroid budenoside may be an effective treatment for patients with refractory celiac disease type 1.
Full story 👉️ buff.ly/Tpb3Opk
#GISky #MedNews
Full story 👉️ buff.ly/Tpb3Opk
#GISky #MedNews
Budenoside reduces refractory symptoms in patients with celiac disease
The synthetic corticosteroid budenoside may be an effective treatment for patients with refractory celiac disease type 1.
www.springermedicine.com
October 24, 2026 at 3:15 PM
From #UEGWeek2026 - The synthetic corticosteroid budenoside may be an effective treatment for patients with refractory celiac disease type 1.
Full story 👉️ buff.ly/Tpb3Opk
#GISky #MedNews
Full story 👉️ buff.ly/Tpb3Opk
#GISky #MedNews
From #UEGWeek2026 - Primary percutaneous stenting may be a better option than endoscopic biliary drainage for managing unresectable malignant hilar biliary obstruction.
Full story 👉️ buff.ly/HrS8xea
#GISky#MedNews
Full story 👉️ buff.ly/HrS8xea
#GISky#MedNews
TESLA study backs primary percutaneous stenting for hilar biliary obstruction
Primary percutaneous stenting may be a better option than endoscopic biliary drainage for managing unresectable malignant hilar biliary obstruction.
www.springermedicine.com
October 25, 2026 at 7:25 PM
From #UEGWeek2026 - Primary percutaneous stenting may be a better option than endoscopic biliary drainage for managing unresectable malignant hilar biliary obstruction.
Full story 👉️ buff.ly/HrS8xea
#GISky#MedNews
Full story 👉️ buff.ly/HrS8xea
#GISky#MedNews
From #UEGWeek2026 - Patients with moderately to severely active ulcerative colitis are significantly more likely to achieve clinical remission after 12 weeks of icotrokinra than placebo.
Full story 👉️ buff.ly/55h7HNB
#GISky #MedNews
Full story 👉️ buff.ly/55h7HNB
#GISky #MedNews
Oral IL-23 receptor inhibition approach feasible for moderately to severely active UC
Patients with moderately to severely active ulcerative colitis are significantly more likely to achieve clinical remission after 12 weeks of icotrokinra than placebo.
www.springermedicine.com
October 24, 2026 at 8:01 AM
From #UEGWeek2026 - Patients with moderately to severely active ulcerative colitis are significantly more likely to achieve clinical remission after 12 weeks of icotrokinra than placebo.
Full story 👉️ buff.ly/55h7HNB
#GISky #MedNews
Full story 👉️ buff.ly/55h7HNB
#GISky #MedNews
From #UEGWeek2026 - Children and adolescents with moderate-to-severe ulcerative colitis may derive long-term benefit from induction therapy with mirikizumab.
Full story 👉️ buff.ly/CFyP2Cs
#MedNews #GISky
Full story 👉️ buff.ly/CFyP2Cs
#MedNews #GISky
Mirikizumab pediatric UC trial results SHINE-2 at UEG Week 2026
Children and adolescents with moderate-to-severe ulcerative colitis may derive long-term benefit from induction therapy with mirikizumab.
www.springermedicine.com
October 23, 2026 at 3:15 PM
From #UEGWeek2026 - Children and adolescents with moderate-to-severe ulcerative colitis may derive long-term benefit from induction therapy with mirikizumab.
Full story 👉️ buff.ly/CFyP2Cs
#MedNews #GISky
Full story 👉️ buff.ly/CFyP2Cs
#MedNews #GISky
Keep up to date with the latest findings, expert insights, and clinical updates from across the spectrum of digestive health with our #UEGWeek2026 congress hub.
Unlock your free access here 👉️ buff.ly/adjbbtY
#GISky #MedSky
Unlock your free access here 👉️ buff.ly/adjbbtY
#GISky #MedSky
October 20, 2026 at 8:02 AM
Keep up to date with the latest findings, expert insights, and clinical updates from across the spectrum of digestive health with our #UEGWeek2026 congress hub.
Unlock your free access here 👉️ buff.ly/adjbbtY
#GISky #MedSky
Unlock your free access here 👉️ buff.ly/adjbbtY
#GISky #MedSky
🤝 A special thank you to everyone who visited our booth, shared their perspectives and explored opportunities to work together, as well as to @myueg.bsky.social and our partners for another valuable edition!
#PatientAdvocacy #UEGWeek2026
@pce-europe.bsky.social @epstoa.bsky.social
#PatientAdvocacy #UEGWeek2026
@pce-europe.bsky.social @epstoa.bsky.social
October 20, 2026 at 4:01 PM
🤝 A special thank you to everyone who visited our booth, shared their perspectives and explored opportunities to work together, as well as to @myueg.bsky.social and our partners for another valuable edition!
#PatientAdvocacy #UEGWeek2026
@pce-europe.bsky.social @epstoa.bsky.social
#PatientAdvocacy #UEGWeek2026
@pce-europe.bsky.social @epstoa.bsky.social
Four days of discussions, research and collaboration at #UEGWeek2026 in Barcelona!
For DiCE, this year's event was an opportunity to bring the experiences and needs of people affected by digestive cancers into conversations on prevention, early detection, screening and research.
For DiCE, this year's event was an opportunity to bring the experiences and needs of people affected by digestive cancers into conversations on prevention, early detection, screening and research.
October 20, 2026 at 4:01 PM
Four days of discussions, research and collaboration at #UEGWeek2026 in Barcelona!
For DiCE, this year's event was an opportunity to bring the experiences and needs of people affected by digestive cancers into conversations on prevention, early detection, screening and research.
For DiCE, this year's event was an opportunity to bring the experiences and needs of people affected by digestive cancers into conversations on prevention, early detection, screening and research.
From #UEGWeek2026 - Budenoside orodispersible tablets at a dose of 2 mg twice daily significantly reduce the formation of esophageal strictures in people with esophageal cancer undergoing endoscopic submucosal dissection.
👉️ buff.ly/C9Zr3pj
#MedNews
👉️ buff.ly/C9Zr3pj
#MedNews
Budenoside tablets protect against esophageal strictures after endoscopic submucosal dissection
Budenoside orodispersible tablets at a dose of 2 mg twice daily significantly reduce the formation of esophageal strictures in people with esophageal cancer undergoing endoscopic submucosal…
www.springermedicine.com
October 22, 2026 at 8:01 AM
From #UEGWeek2026 - Budenoside orodispersible tablets at a dose of 2 mg twice daily significantly reduce the formation of esophageal strictures in people with esophageal cancer undergoing endoscopic submucosal dissection.
👉️ buff.ly/C9Zr3pj
#MedNews
👉️ buff.ly/C9Zr3pj
#MedNews
From #UEGWeek2026 - The burden of disability from alcohol-related cirrhosis and heart failure is predicted to sharply increase in Europe and the USA by 2050.
Full story 👉️ buff.ly/T5cvw1A
#MedNews
Full story 👉️ buff.ly/T5cvw1A
#MedNews
Alcohol-related cirrhosis and heart failure disability increasing across Europe, USA
The burden of disability from alcohol-related cirrhosis and heart failure is predicted to sharply increase in Europe and the USA by 2050.
www.springermedicine.com
October 21, 2026 at 6:25 PM
From #UEGWeek2026 - The burden of disability from alcohol-related cirrhosis and heart failure is predicted to sharply increase in Europe and the USA by 2050.
Full story 👉️ buff.ly/T5cvw1A
#MedNews
Full story 👉️ buff.ly/T5cvw1A
#MedNews
💚 #LIVERAIM joins EASL's #LoveYourLiver at #UEGWeek2026!
🩺 Free, non-invasive liver checks and liver health awareness.
📍 Fira Barcelona Gran Via, outside the North entrance
🤝 Bringing early detection closer to you!
#LIVERAIM #LoveYourLiver
@ihieurope.bsky.social @easlnews.bsky.social
🩺 Free, non-invasive liver checks and liver health awareness.
📍 Fira Barcelona Gran Via, outside the North entrance
🤝 Bringing early detection closer to you!
#LIVERAIM #LoveYourLiver
@ihieurope.bsky.social @easlnews.bsky.social
October 19, 2026 at 2:13 PM
💚 #LIVERAIM joins EASL's #LoveYourLiver at #UEGWeek2026!
🩺 Free, non-invasive liver checks and liver health awareness.
📍 Fira Barcelona Gran Via, outside the North entrance
🤝 Bringing early detection closer to you!
#LIVERAIM #LoveYourLiver
@ihieurope.bsky.social @easlnews.bsky.social
🩺 Free, non-invasive liver checks and liver health awareness.
📍 Fira Barcelona Gran Via, outside the North entrance
🤝 Bringing early detection closer to you!
#LIVERAIM #LoveYourLiver
@ihieurope.bsky.social @easlnews.bsky.social
🎆 FIBROTARGET at #UEGWeek2026!
🗣️ Coordinator Gianluca Matteoli (KU Leuven) presented FIBROTARGET during the session on Gut Fibrosis & Regeneration.
🔬 Learn more about how FIBROTARGET is working to improve the lives of people affected by intestinal fibrosis: https://fibrotarget.eu/
🗣️ Coordinator Gianluca Matteoli (KU Leuven) presented FIBROTARGET during the session on Gut Fibrosis & Regeneration.
🔬 Learn more about how FIBROTARGET is working to improve the lives of people affected by intestinal fibrosis: https://fibrotarget.eu/
October 20, 2026 at 8:14 AM
🎆 FIBROTARGET at #UEGWeek2026!
🗣️ Coordinator Gianluca Matteoli (KU Leuven) presented FIBROTARGET during the session on Gut Fibrosis & Regeneration.
🔬 Learn more about how FIBROTARGET is working to improve the lives of people affected by intestinal fibrosis: https://fibrotarget.eu/
🗣️ Coordinator Gianluca Matteoli (KU Leuven) presented FIBROTARGET during the session on Gut Fibrosis & Regeneration.
🔬 Learn more about how FIBROTARGET is working to improve the lives of people affected by intestinal fibrosis: https://fibrotarget.eu/
Today, during the 2nd day of #UEGWeek2026 in Barcelona, @myueg.bsky.social launched its new Patient Representatives Advisory Board (PRAB), with Zorana Maravic joining as a representative of Digestive Cancers Europe. #PatientAdvocacy #DigestiveHealth
October 18, 2026 at 12:06 PM
Today, during the 2nd day of #UEGWeek2026 in Barcelona, @myueg.bsky.social launched its new Patient Representatives Advisory Board (PRAB), with Zorana Maravic joining as a representative of Digestive Cancers Europe. #PatientAdvocacy #DigestiveHealth
At #UEGWeek2026? Say hello to PCE in the Community Area, Hall 6! 💜
Join #SpotThePurple with the
@EurPancClub: snap something purple for our Pancreatic Cancer Awareness Month mosaic and a chance to win local goodies!
Join #SpotThePurple with the
@EurPancClub: snap something purple for our Pancreatic Cancer Awareness Month mosaic and a chance to win local goodies!
October 18, 2026 at 9:02 AM
At #UEGWeek2026? Say hello to PCE in the Community Area, Hall 6! 💜
Join #SpotThePurple with the
@EurPancClub: snap something purple for our Pancreatic Cancer Awareness Month mosaic and a chance to win local goodies!
Join #SpotThePurple with the
@EurPancClub: snap something purple for our Pancreatic Cancer Awareness Month mosaic and a chance to win local goodies!
A meaningful start to #UEGWeek2026, with more discussions and opportunities for collaboration ahead. Stay tuned for updates!
October 17, 2026 at 2:34 PM
A meaningful start to #UEGWeek2026, with more discussions and opportunities for collaboration ahead. Stay tuned for updates!
We’re at #UEGWeek2026 in Barcelona!
Come and meet the Pancreatic Cancer Europe team in the Community Area, Hall 6, and learn more about our work.
Don’t forget to take part in our Spot the Purple campaign, in collaboration with the European Pancreatic Club, for a chance to win local goodies!
Come and meet the Pancreatic Cancer Europe team in the Community Area, Hall 6, and learn more about our work.
Don’t forget to take part in our Spot the Purple campaign, in collaboration with the European Pancreatic Club, for a chance to win local goodies!
October 18, 2026 at 1:49 PM
We’re at #UEGWeek2026 in Barcelona!
Come and meet the Pancreatic Cancer Europe team in the Community Area, Hall 6, and learn more about our work.
Don’t forget to take part in our Spot the Purple campaign, in collaboration with the European Pancreatic Club, for a chance to win local goodies!
Come and meet the Pancreatic Cancer Europe team in the Community Area, Hall 6, and learn more about our work.
Don’t forget to take part in our Spot the Purple campaign, in collaboration with the European Pancreatic Club, for a chance to win local goodies!
The DiCE team is ready to welcome you to our booth in the community area at #UEGWeek2026 in Barcelona!
Stop by to learn more about our work in digestive cancer prevention, research & patient advocacy, and discover how we’re bringing the patient voice into 🇪🇺 research projects.
@myueg.bsky.social
Stop by to learn more about our work in digestive cancer prevention, research & patient advocacy, and discover how we’re bringing the patient voice into 🇪🇺 research projects.
@myueg.bsky.social
October 17, 2026 at 9:35 AM
The DiCE team is ready to welcome you to our booth in the community area at #UEGWeek2026 in Barcelona!
Stop by to learn more about our work in digestive cancer prevention, research & patient advocacy, and discover how we’re bringing the patient voice into 🇪🇺 research projects.
@myueg.bsky.social
Stop by to learn more about our work in digestive cancer prevention, research & patient advocacy, and discover how we’re bringing the patient voice into 🇪🇺 research projects.
@myueg.bsky.social
Today, DiCE CEO Zorana Maravic joined the Pancreatic Cancer Europe meeting, “Pancreatic Cancer Primary Prevention and Screening Interventions,” on day one in Barcelona!
In her presentation, Zorana highlighted the urgent need for stronger public health action.
#uegweek2026
In her presentation, Zorana highlighted the urgent need for stronger public health action.
#uegweek2026
October 17, 2026 at 2:34 PM
Today, DiCE CEO Zorana Maravic joined the Pancreatic Cancer Europe meeting, “Pancreatic Cancer Primary Prevention and Screening Interventions,” on day one in Barcelona!
In her presentation, Zorana highlighted the urgent need for stronger public health action.
#uegweek2026
In her presentation, Zorana highlighted the urgent need for stronger public health action.
#uegweek2026
📅 CATALYST REMINDER | #$ABVX
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17, 2026 at 7:03 PM
📅 CATALYST REMINDER | #$ABVX
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
Wisepress will be at UEG Week 2026 from 17–20 October.
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
October 17, 2026 at 12:22 PM
Wisepress will be at UEG Week 2026 from 17–20 October.
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
Our Brainstorming Meeting on Pancreatic Cancer Primary Prevention and Screening Interventions has kicked off at #UEGWeek2026 in Barcelona!
Experts and patient advocates are coming together to explore strategies for pancreatic cancer prevention and early detection.
#PancreaticCancer
Experts and patient advocates are coming together to explore strategies for pancreatic cancer prevention and early detection.
#PancreaticCancer
October 17, 2026 at 7:41 AM
Our Brainstorming Meeting on Pancreatic Cancer Primary Prevention and Screening Interventions has kicked off at #UEGWeek2026 in Barcelona!
Experts and patient advocates are coming together to explore strategies for pancreatic cancer prevention and early detection.
#PancreaticCancer
Experts and patient advocates are coming together to explore strategies for pancreatic cancer prevention and early detection.
#PancreaticCancer
Heading to #UEGWeek2026? Looking for something to listen to while travelling?
Catch up on our conversation with Prof. Edoardo Savarino as he looks at how the joint UEG and ESNM #dysphagia guidelines remove uncertainty about its diagnostic work-up and management.
👉️ buff.ly/NukVwtG
#GISky
Catch up on our conversation with Prof. Edoardo Savarino as he looks at how the joint UEG and ESNM #dysphagia guidelines remove uncertainty about its diagnostic work-up and management.
👉️ buff.ly/NukVwtG
#GISky
October 17, 2026 at 8:02 AM
Heading to #UEGWeek2026? Looking for something to listen to while travelling?
Catch up on our conversation with Prof. Edoardo Savarino as he looks at how the joint UEG and ESNM #dysphagia guidelines remove uncertainty about its diagnostic work-up and management.
👉️ buff.ly/NukVwtG
#GISky
Catch up on our conversation with Prof. Edoardo Savarino as he looks at how the joint UEG and ESNM #dysphagia guidelines remove uncertainty about its diagnostic work-up and management.
👉️ buff.ly/NukVwtG
#GISky
Wisepress will be at UEG Week 2026 from 17–20 October.
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
October 4, 2026 at 6:53 AM
Wisepress will be at UEG Week 2026 from 17–20 October.
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
📍 Barcelona, Spain
📅 17–20 October 2026
If you’re attending UEG Week, make sure to stop by and say hello!
#UEGWeek2026
We’re exhibiting at United European Gastroenterology conference week! Meet us in the community Hall! #UEGWeek2026 brings together the gastroenterology community who can directly influence the future of #eosinophilicdisease care. More information here👉https://ow.ly/YHcI50ZLcOh
September 10, 2026 at 11:00 AM
We’re exhibiting at United European Gastroenterology conference week! Meet us in the community Hall! #UEGWeek2026 brings together the gastroenterology community who can directly influence the future of #eosinophilicdisease care. More information here👉https://ow.ly/YHcI50ZLcOh